KyungdongPharm Disclosures

011040 · KOSDAQ · Based on DART filings

Disclosures

2 total · 20 per page

Newest first

Today 4:34 PM· Periodic Report

Q3 revenue KRW 53.1 billion, operating profit KRW 3.9 billion, net loss KRW 1.8 billion

Kyungdong Pharm sold KRW 53.1 billion in Q3 and earned KRW 3.9 billion from its main business, up 25.6% from a year earlier and up 4.7% from the prior quarter.

Oct 30, 2026 3:34 PM· Report on Large Shareholdings

Largest shareholder group acquires 12,000 shares on market, stake at 45.79%

The stake of KyungdongPharm's largest shareholder group rose from 45.75% to 45.79% after a related party acquired 12,000 shares on market at KRW 4,950-5,050 per share.

Catch the next disclosure fast

Get app alerts for new disclosures from KyungdongPharm.